In accordance with the fifth edition of the WHO Classification of haematolymphoid tumors, a distinct type of disease was proposed, namely MDS, with low blasts and SF3B1 mutation (MDS-SF3B1) [1]. Here, SF3B1 is linked to myelodysplastic syndrome.